Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000939767-25-000099
Filing Date
2025-06-04
Accepted
2025-06-04 19:57:38
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749081453.html 4  
1 FORM 4 wk-form4_1749081453.xml 4 5486
  Complete submission text file 0000939767-25-000099.txt   7125
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Issuer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Eckhardt Sue Gail (Reporting) CIK: 0001823769 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30235 | Film No.: 251024710